Three labels on every CBD bottle you'll buy in the UK. They sound technical, they affect what's actually in the product, and they matter more than most first-time buyers realise. A plain-English guide for 2026.
The whole hemp plant, bottled. Everything nature made, including trace THC.
The middle ground. Full cannabinoid complexity minus the THC.
Pure CBD only. Everything else from the hemp plant removed.
Pick up any CBD oil in the UK and one of three words will appear prominently on the label — full-spectrum, broad-spectrum, or isolate. These are not marketing terms. They describe what's actually inside the bottle, and the difference between them affects the price you'll pay, the taste you'll experience, and in some cases whether the product is right for your situation at all.
This guide explains each type in plain terms. By the end, you'll know which label to look for when buying your first or fifth bottle of CBD oil.
Full-spectrum contains every cannabinoid naturally present in hemp, including trace THC. Broad-spectrum removes the THC but keeps everything else. Isolate is pure CBD alone. All three are legal in the UK when other criteria are met. Your choice depends mostly on whether you work in a drug-tested industry and how much cannabinoid complexity you want.
Cannabis sativa — the hemp plant from which all CBD is extracted — contains over a hundred distinct cannabinoid compounds, plus dozens of terpenes and flavonoids. CBD is the best-known of the cannabinoids, but it sits alongside CBG (cannabigerol), CBC (cannabichromene), CBN (cannabinol), CBDA (the acidic precursor to CBD) and, crucially for our purposes, THC (tetrahydrocannabinol) — the psychoactive compound that makes recreational cannabis illegal.
When a brand extracts CBD from hemp, they make a choice about how much of that wider cannabinoid and terpene profile to keep. That choice produces the three categories:
The processing gets progressively more intensive — and expensive — as you move from full-spectrum to isolate. This is counter-intuitive for buyers who assume "purer" means "more expensive." In the CBD market, isolate is often the cheapest of the three on a per-milligram basis precisely because it requires the most processing; the raw plant material matters less when everything but the CBD is removed anyway.
Full-spectrum CBD oils contain the complete cannabinoid and terpene profile of the hemp plant, minus whatever was destroyed by the extraction process. This typically includes measurable quantities of CBD, CBDA, CBG, CBC, trace CBN, the distinct terpene signature of the hemp variety used, and — importantly — trace THC.
The THC in UK full-spectrum products sits under the legal limit of 1mg per container. This is a strict threshold: tighter than most US states, and set by the Misuse of Drugs Act 1971 with criminal penalties for exceeding it. Any full-spectrum product legally sold in the UK has been tested to fall below this line.
The argument for full-spectrum is the entourage effect — a theory that cannabinoids and terpenes work more effectively together than in isolation. The evidence is mixed and ongoing, but it is the primary reason experienced CBD users tend to prefer full-spectrum over isolate. The counter-argument is that trace THC introduces a small residual risk for drug-tested buyers, and that the full-spectrum profile produces a more pronounced, sometimes challenging, hemp-forward taste.
Full-spectrum oils taste of hemp in a way that surprises first-time buyers. Expect something closer to olive oil than to mint — earthy, grassy, slightly bitter.
Broad-spectrum oils start from the same whole-plant extract as full-spectrum, but add an additional processing step to remove the THC while retaining other cannabinoids and terpenes. The most common method is Centrifugal Partition Chromatography, which separates compounds by molecular weight and polarity and allows brands to strip THC to non-detectable levels.
The result: a product that delivers most of the cannabinoid complexity of full-spectrum — CBD, CBG, CBC, trace CBN, terpenes — without the trace THC that some buyers cannot accept. The additional processing costs money, which is why broad-spectrum oils are typically priced similarly to or slightly below full-spectrum equivalents, despite requiring more work.
For drug-tested buyers, broad-spectrum is often the right answer. It delivers meaningful cannabinoid complexity without the legal-but-detectable THC that full-spectrum carries. Naturecan's broad-spectrum oils, for instance, test at under 0.01% THC — twenty times below the UK legal limit and effectively non-detectable on any reasonable workplace drug test.
Not all broad-spectrum is equal. Some brands describe their products as broad-spectrum while still showing detectable THC on published lab reports — "broad-spectrum" is a market description, not a regulated term. If drug-testing is your concern, verify the COA shows THC as non-detectable (usually "<LOQ" or "<0.01%") before buying.
Isolate is pure CBD — typically 99% or higher purity — with every other compound from the hemp plant stripped out. It arrives as a fine, crystalline powder that is then dissolved in a carrier oil (MCT, hemp seed, or occasionally olive) to produce the tincture buyers eventually see on shelves.
The case for isolate is predictability. Because isolate contains only CBD, it behaves consistently batch to batch, has no taste to speak of (most isolate-based products are neutral or subtly flavoured), and carries zero regulatory risk around trace THC. For drug-tested buyers, isolate is the safest available choice.
The case against isolate is what you lose — the minor cannabinoids, the terpenes, and whatever benefits the entourage effect may or may not deliver. For experienced full-spectrum users, isolate can feel thin. For first-time buyers or those with specific drug-test concerns, it can feel reassuringly clean. Cannaray's Night Time Drops, for instance, use isolate deliberately: the brand's argument is that evening dosing benefits from the predictability of a pure compound paired with complementary botanicals like chamomile and passion flower.
The entourage effect is a concept worth understanding because it shapes why buyers pay different prices for the three types. Proposed by Israeli cannabis researcher Raphael Mechoulam in the 1990s, the theory holds that cannabinoids and terpenes produce effects greater than the sum of their parts — that CBD alone does less than CBD accompanied by CBG, CBC, and the terpene profile of the whole plant.
The evidence is genuinely mixed. Some laboratory studies support the theory. Some clinical observations support it. Others do not. As of 2026, it remains a credible hypothesis rather than a proven mechanism, and the Advertising Standards Authority has explicitly cautioned UK brands against marketing the entourage effect as an established fact.
Our view: if the entourage effect matters to you, full-spectrum is the right choice. If you're unsure whether it matters, broad-spectrum gives you most of the theoretical benefits without the THC. If predictability matters more than complexity, isolate is the sensible default. All three positions are defensible.
All three types — full-spectrum, broad-spectrum, and isolate — are legal in the UK when other compliance criteria are met. The type of CBD does not change the legal framework that applies.
Every legally sold CBD product in the UK must:
These apply equally to all three types. A full-spectrum oil can be legal; a poorly-produced isolate can be illegal if its paperwork isn't in order. The type tells you about the cannabinoid profile, not the regulatory status. Verify Novel Foods listing separately regardless of which type you buy. Our dedicated legal guide covers this in full.
Strength is determined by CBD milligrams, not by type. A 1000mg isolate tincture contains the same 1000mg of CBD as a 1000mg full-spectrum tincture. The difference is what else accompanies it.
Isolate typically has the least taste and is the easiest to flavour cleanly. Broad-spectrum sits in the middle. Full-spectrum carries the most pronounced hemp-forward flavour and is usually described by first-time buyers as bitter or earthy.
Often, yes. Full-spectrum oils are typically darker — golden, amber, or green — because they retain chlorophyll and plant pigments. Broad-spectrum is lighter. Isolate in a neutral carrier like MCT oil is typically almost clear, sometimes faintly pale.
Pricing varies, but as a rough guide: isolate is often the cheapest per milligram of CBD, broad-spectrum sits in the middle, and full-spectrum commands a small premium because the raw plant material does more of the work. Premium brands push full-spectrum pricing further up by emphasising minor cannabinoid content.
No. Most people find the type that works for their situation and stick with it. If you're undecided, start with broad-spectrum — it's the middle ground, covers most use cases, and avoids the drug-test complication of full-spectrum.
No. UK legal limits ensure that even full-spectrum products contain far too little THC to produce any psychoactive effect. The trace THC in full-spectrum is relevant only for drug-test sensitivity, not for recreational effects.
Full-spectrum contains trace THC and the full cannabinoid profile. Broad-spectrum removes the THC but keeps cannabinoid complexity. Isolate is pure CBD only. All three are legal when other criteria are met. If you're drug-tested, choose broad-spectrum or isolate. If you're not and you want the full entourage profile, choose full-spectrum. If you're uncertain, broad-spectrum is the sensible default.